CompletedNot Applicable

Recurrence of Odontogenic Keratocyst

Egypt48 participantsStarted 2022-12-02

Plain-language summary

The aim of current cross over clinical trial is to evaluate the effect of topical 5-FU as adjunct therapy in reducing risk of the recurrence of OKCs

Who can participate

Age range20 Years – 50 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * patients with biopsy proved odontogenic keratocyst Exclusion Criteria: * relevant systemic diseases which might affect healing process.

What they're measuring

degree of pain

Timeframe: 6 month

swelling

Timeframe: 6 month

Trial details

NCT IDNCT06071806

SponsorTanta University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-03-10

View on ClinicalTrials.gov More Odontogenic Cyst trials